Mic***PhD

Corporate Development

Bildung

Massachusetts Institute of Technology

Massachusetts Institute of Technology (2005 - 2007)

  • Degree: Master of Business Administration - MBA
  • Field of Study: Unknown Field
  • Description:

Massachusetts Institute of Technology - Sloan School of Management (2005 - 2007)

  • Degree: MBA
  • Field of Study: Entrepreneurship and Technology Strategy
  • Description: • Teaching Assistant - New Enterprises (Prof. Noubar Afeyan) • Life Science Panel Lead - MIT Venture Capital Conference

UAB School of Medicine (2002 - 2005)

  • Degree: PhD
  • Field of Study: Cell Biology
  • Description: • Research focus: Understanding the role of TGF-beta signaling in the development of the axial skeleton. • Invited speaker at the Federation of American Societies for Experimental Biology, Transforming Growth Factor-beta Conference, July 2003 • Authored publications in the Journal of Biological Chemistry, European Journal of Biochemistry and Developmental Biology

Fähigkeiten:

Rare Diseases, Private Equity, Non-Governmental Organizations (NGOs), Public Health

Berufserfahrung:

Corporate Development at Maravai LifeSciences

  • Location: San Francisco Bay Area
  • Duration: 2021-03 to Present
  • Description: Michael leads the corporate development function at Maravai, covering M&A, strategic partnerships, and investments.

Corporate Business Development at Illumina

  • Location: San Francisco Bay Area
  • Duration: 2018-05 to 2021-03
  • Description: Corporate Business Development leader of inorganic strategy and partnerships in emerging clinical applications for genomics driven drug discovery, clinical development, and molecular diagnostics.

Global Health Leader at Thermo Fisher Scientific

  • Location: San Francisco Bay Area
  • Duration: 2016-01 to 2018-05
  • Description: GM of Global Public Health business vertical within the Genetic Sciences Division of Thermo Fisher Scientific. Full matrix ownership of strategy, product development, R&D, marketing, and commercial execution. Corporate leader of genetic analysis initiatives for (1) National Public Health Surveillance for infectious and genetic diseases, (2) Global pandemic response, and (3) Strategic relationship owner for global NGO partnerships.

Strategy & Corporate Development at Thermo Fisher Scientific

  • Location: San Francisco Bay Area
  • Duration: 2013-03 to 2016-01
  • Description: • Genomic Platforms Strategy Leader (NGS, qPCR, CE) • Corporate Strategy Leader, Life Technologies (acquired by Thermo Fisher Scientific, 2014) Corporate and Divisional Strategy Leader, responsible for the development of annual strategic plans, advisory support for M&A and BD deal teams, early engagement with strategic partners, and management of consulting services.

Corporate Development at Novartis, Molecular Diagnostics

  • Location: Greater San Diego Area
  • Duration: 2012-01 to 2012-12
  • Description:
KI-Lebenslaufanalyse

Kandidaten-Intelligenzbericht

KI-gestützte Analyse aus der Perspektive eines US-Einstellungsdirektors — Bewertung von Karrierekontinuität, Wachstumstrajektorie und Rollenpassung.

Karrierekontinuität und Risikobewertung

Employment GapLow

No significant employment gaps are evident. A minor gap of a few weeks between 2012-12 and 2013-03 is common in transitions and does not indicate disruption.

Industry ConsistencyLow

All roles are within life sciences, biotech, and molecular diagnostics, demonstrating a consistent industry focus.

Tenure StabilityMedium

Past short tenure at Novartis (12 months) introduces some instability signal, but subsequent roles show multi-year durations with increasing scope, mitigating overall risk.

Education-Career MatchLow

Educational background (PhD in life sciences, MIT Sloan MBA, and related chemistry/physiology degrees) directly supports senior corporate development roles in biotech and pharma.

Karrierewachstumskurve

Corporate Development Entry
Novartis, Molecular Diagnostics
2012-01 to 2012-12
Strategy & Corporate Development ↑ Befördert
Thermo Fisher Scientific
2013-03 to 2016-01
Global Health Leader ↑ Befördert
Thermo Fisher Scientific
2016-01 to 2018-05
Corporate Business Development ↑ Befördert
Illumina
2018-05 to 2021-03
Corporate Development ↑ Befördert
Maravai LifeSciences
2021-03 to Present
Bewertung:Michael demonstrates a clear, upward trajectory in corporate development and strategy within leading life sciences organizations. The progression to higher strategic scope and P&L/vertical leadership suggests readiness for senior executive roles such as Chief Corporate Development Officer or Head of Corporate Development at a top-tier biopharma/genomics company.

Bestpassende Rollen (Top 5)

1

Chief Corporate Development Officer95% Passung

Extensive leadership across M&A, partnerships, and investments in top life sciences firms, with current C-level-like responsibility at Maravai. MBA plus PhD strongly supports strategic, financial, and operational rigor required at the C-suite level.

2

Senior Vice President, Corporate Development90% Passung

Proven track record of driving inorganic growth and strategic partnerships across genomics, diagnostics, and biopharma. Experience aligns with SVP-level ownership of global BD and strategy.

3

Vice President / Head of Corporate Strategy & Development88% Passung

Deep experience in strategy development, portfolio planning, and partner management; fits a high-level role focusing on long-range strategic planning and deal execution.

4

Global Head of Strategic Partnerships & Alliances83% Passung

Strong history managing global NGO partnerships and cross-functional alliances; suitable for a role overseeing multi-regional partnerships and external collaborations.

5

Senior Director / Vice President, Business Development & Licensing (Rare Diseases)78% Passung

Rare diseases expertise and BD/ Licensing focus align with growth-stage biotech needs; well-suited for leading licensing initiatives and external collaborations in a disease-focused company.

Erleben Sie AI Recruiter

Kostenlos starten. Lassen Sie Ihre Konkurrenten nicht den KI-Vorteil zuerst ergattern.

Schließen Sie sich über 10.000 Unternehmen an, die KI-gestützte Recruiting-Lösungen nutzen, um Ihren Einstellungsprozess zu automatisieren und 80% Zeitkosten zu sparen.

33% Rabatt, nur noch 48 Stunden!
Kostenlos AI testen

24/7 automatisierter Betrieb

KI-gestützte Kandidatenauswahl

Recruiting ohne geografische oder zeitliche Einschränkungen

Personalisierte intelligente Kommunikation

Automatisierte Bewertung des Kandidatenengagements

Ahmt Ihren Recruiting-Stil intelligent nach

4-monatige Geld-zurück-Garantie

Gewährleistet LinkedIn-Kontosicherheit